Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.19.3.a.u2
Consolidated Statements of Operations - USD ($)
3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Consolidated Statements of Operations    
Revenues $ 0 $ 0
Operating expenses:    
General and administrative expenses 975,833 1,178,622
Research and development expenses 643,734 589,202
Total operating expenses 1,619,567 1,767,824
Operating loss (1,619,567) (1,767,824)
Other expense    
Increase to fair value of derivative (40,187) (832,413)
Total other expense (40,187) (832,413)
Net loss $ (1,659,754) $ (2,600,237)
Earnings per share - basic and diluted    
Net loss per common share - basic and diluted $ (0.01) $ (0.02)
Weighted common shares - basic and diluted 184,102,916 161,057,300